Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Ellepola AN et al. | Adhesion of oral Candida species to human buccal epithelial cells following brief exposure to nystatin. | 1999 | Oral Microbiol. Immunol. | pmid:10895691 |
Kuriyama T et al. | In vitro susceptibility of oral Candida to seven antifungal agents. | 2005 | Oral Microbiol. Immunol. | pmid:16238594 |
Chami N et al. | Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo. | 2005 | Oral Microbiol. Immunol. | pmid:15720571 |
Silva MM et al. | Comparison of denture microwave disinfection and conventional antifungal therapy in the treatment of denture stomatitis: a randomized clinical study. | 2012 | Oral Surg Oral Med Oral Pathol Oral Radiol | pmid:22986242 |
Kaomongkolgit R et al. | Antifungal activity of coronarin D against Candida albicans. | 2012 | Oral Surg Oral Med Oral Pathol Oral Radiol | pmid:22727093 |
Willis AM et al. | The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus. | 2001 | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | pmid:11250629 |
Negm MM | Intracanal use of a corticosteroid-antibiotic compound for the management of posttreatment endodontic pain. | 2001 | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | pmid:11598580 |
Epstein JB et al. | Oral candidiasis in hematopoietic cell transplantation patients: an outcome-based analysis. | 2003 | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | pmid:12931087 |
Hamers AD et al. | Use of a microtiter plate assay to detect the rate of killing of adherent Candida albicans by antifungal agents. | 1996 | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | pmid:8850482 |
Ates M et al. | The effect of calcium chelating or binding agents on Candida albicans. | 2005 | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | pmid:16243251 |